Skip to main content
Health
Insurance
Retirement & Benefits
Risk
Careers
About
Contact Us
Search
Loading...
Peter Chang
Senior Actuarial Analyst
Brookfield, WI, US
Message
Download bio
Download
Download vCard
Download
TOP
Contact
Experience
Publications
Read their latest work
Article
Biosimilar Utilization at 340B and Non-340B Outpatient Hospitals in the Commercial Market
17 November 2022 - by Katherine M. Holcomb, Peter Chang
Our study shows biosimilar use at 340B outpatient hospitals is lower than that at non-340B facilities, while reference products have higher patient costs.